International Journal of STD & AIDS > Volume 17, Number 1 > Pp. 63-64

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Fowler, A Articles by Bradbeer, C Search for Related Content PubMed PubMed Citation Social Bookmarking                      What's this?

Case reports

Multicentric Castleman's disease in a patient with HIV

A Fowler, L Collins, A de Ruiter, S Whittaker, R Kulasegaram and C Bradbeer

Department of Genito-urinary Medicine, Guy's and St Thomas' NHS Foundation Trust, London SE7 7EH, UK; Department of Genito-urinary Medicine, Guy's and St Thomas' NHS Foundation Trust, London SE7 7EH, UK; Department of Genito-urinary Medicine, Guy's and St Thomas' NHS Foundation Trust, London SE7 7EH, UK; Department of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London SE7 7EH, UK; Department of Genito-urinary Medicine, Guy's and St Thomas' NHS Foundation Trust, London SE7 7EH, UK; Department of Genito-urinary Medicine, Guy's and St Thomas' NHS Foundation Trust, London SE7 7EH, UK

Multicentric Castleman's disease (MCD) was originally described in non-HIV patients. It is a rare lymphoproliferative disorder, which is more commonly seen in HIV-positive patients and is associated with human herpes virus-8 (HHV-8). We describe a patient with advanced HIV who responded well to conventional highly active antiretroviral treatment. She was diagnosed with MCD soon after her diagnosis of HIV. She presented with multiple flares of her MCD. The case illustrates the difficulty of differentiating between episodes of septicaemia and a flare of MCD. The patient was treated with various chemotherapy regimens, which included several cycles of liposomal doxyrubicin and etoposide. There is currently no consensus on the treatment of MCD and various therapies are described in the literature, which include chemotherapy. Chemotherapy must be chosen with the immunosuppressive effects of the treatment being considered with caution. Both doxyrubicin and etoposide are well tolerated and successfully controlled the symptoms of MCD in our patient.

Key Words: MULTICENTRIC CASTLEMAN'S DISEASE • HUMAN HERPES VIRUS 8 • SEPTICAEMIA • CHEMOTHERAPY

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?